Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 70518-1063

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-1063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Glipizide extended-release film-coated tablets, 5 mg strength, with a quantity of 30 tablets. The label shows it is repackaged by RemedyRepack Inc., with storage instructions and manufacturer noted as Rising Pharma, Inc., Allendale, NJ. The label includes NDC 70518-1063, a barcode, and a QR code.*

FDA Label Image

Mm2 (Glipizide 5mg 70518 1063 01)

Label for Glipizide 5 mg extended-release film-coated tablets, with a quantity of 90 tablets. The label indicates RX only and provides the NDC 70518-1063-01. Manufactured by Rising Pharma, Inc., Allendale, NJ. The label includes storage instructions and repackaging information by RemedyRepack Inc., Indiana, PA. A barcode and QR code are visible on the label.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of glipizide, displaying the molecular arrangement of atoms including a methyl-substituted pyridine ring, sulfonylurea group, and cyclohexyl moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.